2-(5-((2-oxo-2-(phenylamino)ethyl)thio)-4H-1,2,4-triazol-3-yl)benzoic acid

ID: ALA3577961

Chembl Id: CHEMBL3577961

PubChem CID: 122178131

Max Phase: Preclinical

Molecular Formula: C17H14N4O3S

Molecular Weight: 354.39

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  O=C(CSc1nnc(-c2ccccc2C(=O)O)[nH]1)Nc1ccccc1

Standard InChI:  InChI=1S/C17H14N4O3S/c22-14(18-11-6-2-1-3-7-11)10-25-17-19-15(20-21-17)12-8-4-5-9-13(12)16(23)24/h1-9H,10H2,(H,18,22)(H,23,24)(H,19,20,21)

Standard InChI Key:  QKJSCJMJRUXEEC-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA3577961

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 354.39

Molecular Weight (Monoisotopic): 354.0787

AlogP: 2.90

#Rotatable Bonds: 6

Polar Surface Area: 107.97

Molecular Species: ACID

HBA: 5

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 3.21

CX Basic pKa: 1.42

CX LogP: 2.35

CX LogD: -1.00

Aromatic Rings: 3

Heavy Atoms: 25

QED Weighted: 0.59

Np Likeness Score: -1.73

References

1. Yang SK, Kang JS, Oelschlaeger P, Yang KW..  (2015)  Azolylthioacetamide: A Highly Promising Scaffold for the Development of Metallo-β-lactamase Inhibitors.,  6  (4): [PMID:25893049] [10.1021/ml500534c]

Source

Source(1):

• Scientific Literature